Comerica Bank’s abrdn Life Sciences Investors HQL Stock Holding History

Comerica Bank’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$78.5K	Buy	4,678 +44	+0.9%	+$739	﹤0.01%	2707
2025 Q3	$71.9K	Buy	4,634 +206	+5%	+$2.82K	﹤0.01%	2728
2025 Q2	$56.7K	Buy	4,428 +276	+7%	+$3.4K	﹤0.01%	2770
2025 Q1	$52.7K	Buy	4,152 +151	+4%	+$2.04K	﹤0.01%	2775
2024 Q4	$52.5K	Buy	4,001 +178	+5%	+$2.57K	﹤0.01%	2788
2024 Q3	$57.7K	Buy	3,823 +114	+3%	+$1.73K	﹤0.01%	2750
2024 Q2	$52.5K	Sell	3,709 -180	-5%	-$2.43K	﹤0.01%	2735
2024 Q1	$53K	Sell	3,889 -21	-0.5%	-$291	﹤0.01%	2754
2023 Q4	$52.6K	Buy	3,910 +543	+16%	+$6.68K	﹤0.01%	2707
2023 Q3	$42K	Buy	+3,367	New	+$44.3K	﹤0.01%	2754

Other funds holding HQL

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Comerica Bank's HQL Position: Q4 2025 in Review

Comerica Bank increased its abrdn Life Sciences Investors (HQL) stake by 0.95% in Q4 2025, buying an estimated $739 and bringing the position to 4,678 shares worth $78.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

Comerica Bank first reported a position in HQL in Q3 2023 and has held it in 10 quarters since. 73 funds tracked by Wall St. Rank hold HQL as of Q4 2025.

Comerica Bank held 4,678 shares of abrdn Life Sciences Investors worth $78.5K as of Q4 2025.
Comerica Bank bought 44 abrdn Life Sciences Investors shares in Q4 2025, an estimated $739.
abrdn Life Sciences Investors made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2707 holding.
Comerica Bank first reported a position in abrdn Life Sciences Investors in Q3 2023 and has held it in 10 quarters since.
73 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.